Related Experiment Videos

[Clinical pharmacokinetics and the optimal intravenous ampicillin administration regimen in children]

Antibiotiki
|February 1, 1981
PubMed

Insights

This study determined optimal ampicillin dosing for pediatric acute pneumonia. A two-compartmental model informed a regimen providing effective antibiotic levels in children.

Area of Science:

  • Pediatric Pharmacology
  • Infectious Diseases
  • Pharmacokinetics

Context:

  • Acute pneumonia is a common childhood illness requiring effective antibiotic treatment.
  • Ampicillin is a frequently prescribed antibiotic for bacterial infections in children.
  • Understanding drug pharmacokinetics is crucial for optimizing pediatric dosing regimens.

Purpose:

  • To investigate the pharmacokinetics of ampicillin in children with acute pneumonia.
  • To develop an optimized intravenous dosing regimen for ampicillin in this population.
  • To validate the calculated regimen through clinical observation.

Summary:

  • Nineteen children (3 months–3 years) received intravenous ampicillin (25 mg/kg).
  • A two-compartmental model best described ampicillin's pharmacokinetic profile, with a half-life of 37 minutes and clearance of 7.3 ml/min·kg.
  • An optimized regimen (3.5 mg/kg loading dose, 70 µg/min·kg infusion) was calculated and showed good correlation with observed serum levels in 7 children.

Impact:

  • Provides a data-driven, optimized ampicillin dosing strategy for pediatric acute pneumonia.
  • Enhances therapeutic efficacy and potentially reduces adverse events through precise drug level management.
  • Contributes to evidence-based guidelines for antibiotic use in pediatric infectious diseases.

Related Concept Videos